Inotiv (NOTV) Liabilities and Shareholders Equity (2010 - 2026)
Inotiv (NOTV) reported Liabilities and Shareholders Equity of $702.4 million for Q1 2026, down 8.3% on a YoY basis from $766.0 million in Q1 2025, and down 4.35% quarter-over-quarter from $734.3 million in Q4 2025.
Inotiv (NOTV) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Inotiv has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $702.4 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 8.3% year-over-year to $702.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 billion (down 4.11% YoY), and the FY2025 full-year result was $771.1 million, down 1.31% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $702.4 million, down from $734.3 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $1.2 billion in Q2 2022, with the low at $702.4 million in Q1 2026.
- Historically, Liabilities and Shareholders Equity has averaged $849.1 million across 5 years, with a median of $815.4 million in 2024.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 1664.6% — and 2023, when it retreated 26.8%.
- Inotiv's Liabilities and Shareholders Equity stood at $871.1 million in 2022, then slipped by 4.08% to $835.5 million in 2023, then retreated by 7.49% to $772.9 million in 2024, then declined by 4.99% to $734.3 million in 2025, then declined by 4.35% to $702.4 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $702.4 million (Q1 2026), $734.3 million (Q4 2025), and $771.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 13.07 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 29.68 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Inotiv | 3.24 Mn | -11.94 Mn | 111.99 Mn | 702.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 702.42 Mn |
| Dec 31, 2025 | 734.34 Mn |
| Sep 30, 2025 | 771.11 Mn |
| Jun 30, 2025 | 759.74 Mn |
| Mar 31, 2025 | 765.97 Mn |
| Dec 31, 2024 | 772.91 Mn |
| Sep 30, 2024 | 781.36 Mn |
| Jun 30, 2024 | 774.59 Mn |
| Mar 31, 2024 | 815.38 Mn |
| Dec 31, 2023 | 835.51 Mn |
| Sep 30, 2023 | 856.53 Mn |
| Jun 30, 2023 | 854.83 Mn |
| Mar 31, 2023 | 868.67 Mn |
| Dec 31, 2022 | 871.06 Mn |
| Sep 30, 2022 | 962.90 Mn |
| Jun 30, 2022 | 1.17 Bn |
| Mar 31, 2022 | 1.14 Bn |
| Dec 31, 2021 | 1.00 Bn |
| Sep 30, 2021 | 321.86 Mn |
| Jun 30, 2021 | 176.74 Mn |